Eco antibiotic drives strong sales growth; Patterson declares cash dividend; UC Davis scientists report success preventing tumors in foxes;

> Eco Animal Health reported that in the 6 months ended Sept. 30, its revenues jumped 27% year-over-year to £21.5 million ($32.5 million) and its adjusted earnings before taxes, depreciation and amortization rose 26% to £4.3 million ($6.5 million), driven largely by demand for its poultry and swine antibiotic Aivlosin. Release

> Patterson Companies ($PDCO) declared a quarterly cash dividend of $0.22 per share, payable January 22. Release

> Wildlife specialists at the University of California, Davis, reported in the journal PLOS ONE that by administering a commonly used treatment for ear mites in dogs and cats called acaracide to wild foxes on Catalina Island, they reduced ear mite infection rates from 98% to 10%, greatly decreasing inflammation of the animals' ear canals, which can lead to tumors when untreated. Release

> Bravo Pet Foods announced it is recalling a lot of Bravo Chicken Blend diet for dogs and cats and three additional products manufactured the same day due to possible contamination with Salmonella. Release